Geng, Shengjun
Peng, Wen
Wang, Xue
Hu, Xiaosong
Liang, Hanghua
Hou, Jianbing
Wang, Feng
Zhao, Gaichao
Lü, Muhan
Cui, Hongjuan https://orcid.org/0000-0003-1178-1570
Article History
Received: 16 September 2021
Revised: 1 May 2022
Accepted: 23 May 2022
First Online: 22 June 2022
Competing interests
: The authors declare no competing interests.
: All experiments involving cancer patients’ samples were obtained from Chaoying Biotechnology Co., Ltd. (Xian, China), and the studies were approved by the Medical Ethics Committee of Tongxu County People’s Hospital of Henan Province. All of the patients were informed consent.